Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates

Pediatrics

Volumn 122, Issue 1, 2008, Pages 34-39

  Ongkasuwan, Julina ^a   Valdez, Tulio A ^a,b   Hulten, Kristina G ^a,b   Mason, Edward O ^a,b   Kaplan, Sheldon L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Mastoiditis; Serotype 19A; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; VACCINE;

ABSCESS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; MALE; MASTOIDECTOMY; MASTOIDITIS; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROTYPING; SIGMOID SINUS THROMBOSIS; STREPTOCOCCUS PNEUMONIA 19A; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; ANTIBIOTIC RESISTANCE; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RADIOGRAPHY; STREPTOCOCCUS INFECTION; TEMPORAL BONE;

CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT; MALE; MASTOIDITIS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TEMPORAL BONE; TOMOGRAPHY, X-RAY COMPUTED; VACCINES, CONJUGATE;

EID: 48249093468     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2703     Document Type: Article

References (30)

1. Blevins NH, Lalwani AK. Acute mastoiditis. In: Lalwani AK, Grundfast KM, eds. Pediatric Otology and Neurotology. Philadelphia, PA: Lippincott-Raven; 1998:265-275
2. Fliss DM, Leiberman A, Dagan R. Acute and chronic mastoiditis in children. Adv Pediatr Infect Dis. 1997;13:165-185
3. Van Zuijlen DA, Schilder AGM, Van Balen FAM, Hoes AW. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media. Pediatr Infect Dis J. 2001;20(2):140-144
4. Katz A, Leibovitz E, Greenberg D, et al. Acute mastoiditis in southern Israel: a year retrospective study (1990 through 2001). Pediatr Infect Dis J. 2003;22(10):878-882
5. Spiegel JH, Lustig LR, Lee KC, Murr AH, Schindler RA. Contemporary presentation and management of a spectrum of mastoid abscesses. Laryngoscope. 1998;108(6):822-828
6. Nadal D, Herman P, Baumann A, et al. Acute mastoiditis: clinical, microbiological, and therapeutic aspects. Eur J Pediatr. 1990;149(8):560-564
7. Gliklich RE, Eavey RD, Iannuzzi RA, Camacho AE. A contemporary analysis of acute mastoiditis. Arch Otolaryngol Head Neck Surg. 1996;122(2):135-139
8. Kaplan SL, Mason EO Jr, Wald ER, et al. Pneumococcal mastoiditis in children. Pediatrics. 2000;106(4):695-699
9. Whitney CG, Pickering LK. The potential of pneumococcal conjugate vaccines for children. Pediatr Infect Dis J. 2002; 21(10):961-970
10. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein- polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-1746
11. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113(3): 443-449
12. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopha- ryngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185(7):927-936
13. Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneu- mococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26(6): 468-472
14. Messina AF, Katz-Gaynor K, Barton T, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antibiotic resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J. 2007;26(6):461-467
15. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403-409
16. Pai R, Moore MR, Pilishvili T, et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis. 2005;192(11):1988-1995
17. Jacobs MR, Good CE, Sellner T, Bajaksouzian S, Windau A, Anon JB. Nasopharyngeal carriage of respiratory pathogens in children undergoing pressure equalization tube placement in the era of pneumococcal protein conjugate vaccine use. Laryngoscope. 2007;117(2):295-298
18. Singleton RJ, Hennessey TW, Bulkow LR, et al. Invasive pneu- mococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumo- coccal conjugate vaccine coverage. JAMA. 2007;297(16):1784 -1792
19. Pichichero ME, Casey JR. Emergence of a multiresistant sero- type 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772-1778
20. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneu- mococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998 -2004. J Infect Dis. 2007;196(9): 1346 -1354
21. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Testing: Seventeenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007. CLSI document M100-S17
22. McEllistrem MC, Pass M, Elliott JA, Whitney CG, Harrison LH. Clonal groups of penicillin-nonsusceptible Streptococcus pneu- moniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. J Clin Microbiol. 2000;38(12):4367-4372
23. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Micro- biol. 1995;33(9):2233-2239
24. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144(Pt 11):3049-3060
25. Gertz RE Jr, McEllistrem MC, Boxrud DJ, et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol. 2003;41(9):4194-4216
26. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumo- coccal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295(14):1668 -1674
27. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118(3):865-873
28. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of conjugate pneumococcal vaccine. Pediatrics. 2007;119(4):707-715
29. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneu- mococcal parapneumonic empyema. Pediatr Infect Dis J. 2006; 25(3):250-254
30. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis. 1995;171(4):885-889